Julie L. Gerberding, EVP, Chief Patient Officer at Merck & Co., Inc. (MRK), sold 192,540 shares at $87.91 ($16.9M) on 2021-11-01, disclosed to the SEC on 2021-11-03.
Open-market sale of $16.9M MRK by EVP, Chief Patient Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.91 | 96,270 | $8.5M | 50.0% |
| 2 | $87.91 | 96,270 | $8.5M | 50.0% |
| Total | $87.91 avg | 192,540 | $16.9M | 100% |
| Filing → |
| CERN | SELL | 2019-08-23 | $1.1M | — | Filing → |
| MRK | SELL | 2018-11-08 | $5.4M | — | Filing → |
| MRK | SELL | 2018-05-16 | $1.2M | — | Filing → |